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The use of nanoparticles (NPs) has increased in the past few years in various ﬁelds, including
defence, aerospace, electronics, biology, medicine, and so forth. and in applications such as
diagnostic technology, bioimaging, and drug/gene delivery. Thus, human exposure to NPs and
nanomaterials is unavoidable and will certainly expand in the future resulting in a growing interest
in nanotoxicology, the study of toxicity of nanomaterials. A number of studies have reported the
effects of NPs in respect to pulmonary inﬂammation by investigating in vitro activation of pulmo-
nary cells with NPs and in vivo in a variety of models in which neutrophils appear to be the
predominant leukocyte cell type in lungs and in bronchoalveolar lavages following inhalation or
intratracheal instillation of NPs. Despite the fact that several studies have reported an increased
number of neutrophils, the literature dealing with the direct activation of neutrophils by a given NP
is poorly documented.This paperwill summarize thecurrent literature in this latter area of research
and will end with a perspective view in which our laboratory will be involved in the following years.
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1. FROM NANOBIOTECHNOLOGY TO NANOTOXICOLOGY
Thepreﬁx“nano”is derivedfrom the Greek“nanos”means“dwarf”andisbecomingincreasinglyprevalent
in scientiﬁc literature. Theconceptofnanotechnologyitself is notrecentandis usuallyattributed to a speech
made by Dr. Richard Feynman, a well-known American physicist, at the December 1959 meeting of the
American Physical Society where he asked: “What would happen if we could arrange the atoms one by one
the way we want them? [1]. Research in the nanotechnology ﬁeld is growing at breathtaking speed, and the
reason is simple: nanomaterials are expectedto improve virtually all types of products [2, 3]. Nanoparticles
(NPs) are deﬁned as small-scale substances (at least one dimension <100nm) with unique properties,
whereas nanomaterials are deﬁned as small-scale substances engineered to achieve unique mechanical,
optical, electrical, andmagnetic properties [4, 5]. While emerging nanotechnologieshavegreat potential for
human needs, there is increasing concern that the same features that make them interesting also represent
a menace to human health [6]. Consequently, a new branch of toxicology, nanotoxicology, has recently
emerged. This ﬁeld, which can be deﬁned as the evaluation of safety of engineered nanostructures and
nanodevices, is growing rapidly, since information about safety and potential hazards is urgently need-
ed. Exposure to NPs has increased dramatically in the past few years due to anthropogenic sources
given that NPs can be formed via a wide variety of processes/methods. These sources are numerous and
include internal combustion engines, power plants, and many other sources of thermodegradation [7]. Fur-
thermore, intense research and development by the industry and academia multiply the number of indi-
viduals potentially exposed to NPs.
Nanotoxicology is, therefore, a very complex discipline, and the diversity and complexity of NPs
makes chemical characterization not only more important but also more difﬁcult [8].
2. INFLAMMATION: POSITIONING NEUTROPHILS
Inﬂammation is a normal biological response of the body to various assaults, including microorganisms,
injuries, dusts, drugs, and other chemicals. Under normal circumstances, inﬂammation will subside and
resolve itself in an individual through a series of tightly regulated responses. However, when deregulation
occurs, inﬂammation can lead to inﬂammatory disorders and diseases including asthma and several
pulmonary lung diseases, dermatitis, arthritis, inﬂammatory bowel diseases, and so forth, [9, 10]. During
acute inﬂammation, polymorphonuclear neutrophil cells (PMNs) are the ﬁrst type of leukocytes to migrate
to an inﬂammatory site, where they will produce several proinﬂammatory mediators including chemokines
that ﬁrst attract other PMNs and then other cell types like monocytes-macrophages and lymphocytes,
corresponding to chronic inﬂammation.
PMNs are phagocytes well recognized for their ability to eliminate bacteria and fungi. These cells
eliminate invading pathogens via two important mechanisms: (i) the respiratory burst, which is an oxygen-
dependent process leading to the generation of reactive oxygen species (ROS) and (ii) degranulation,
an oxygen-independent mechanism by which PMNs release potent toxic degradative products stored in
granules. In addition to reactive oxygen metabolites and granule enzymes, PMNs are known to be an im-
portant source of products implicated in tissue damage and inﬂammation such as leukotriene B4, platelet-
activating factor, and various cytokines (IL-1α, IL-8, IL-12, TNF-α,T G F - β, and GRO-α), to name a few
[9] .T h ei m p o r t a n c eo fP M N si ni n ﬂammation is further supported by the observation that various PMN
priming and activating agents such as IL-1β, IL-8, IL-15, GM-CSF, TGF-β, C5a, C9, and so forth, are
present, for example, in the synovial ﬂuids of rheumatic patients [11–13].
In humans, PMNs are the most abundant leukocytes in circulation, representing more than 65% of
this blood cell population. Theyare terminally nondividingcells which developin bone marrow. It has been
estimated that about 5 × 1010cells/day are released from bone marrow into circulation in a normal adult
[14, 15]. Therefore, cell turnover must be under strict control in order to prevent diseases. The number of
PMNs remains relatively constant in healthy individuals, and this is due to the limited lifespan (half-life of
∼12h in circulation) of these cells and the fact that they spontaneouslyundergo apoptosis. Identiﬁcation of
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pro- or antiapoptotic agents is of major importance, since resolution of inﬂammation occurs by elimination
of apoptotic PMNs by professional phagocytes such as macrophages. When the rate of PMN apoptosis is
accelerated, this results in an increase in bacterial susceptibility. In contrast, when apoptosis is delayed or
suppressed, this can aggravate inﬂammation and lead to autoimmune disorders. It is important to mention
that the same arsenal and biological responses of PMNs involved in host defence can also be deleterious
for an organism when deregulation occurs. This phenomenon is known as the neutrophil paradox in which
the defending cell becomes an enemy. Because of this, and knowing the role of PMNs during inﬂammation
(PMNs are seen as conductors of inﬂammation), it is very important to carefully understand the mode of
action of PMN agonists as well as to identify new ones. Of note, even if an agent is not a direct PMN ago-
nist by itself, it can be indirectly proinﬂammatory by attracting these cells in vivo, as is the case with IL-21
[16, 17].
Curiously, despite the importance of PMNs in the inﬂammatory process and the fact that several
studies have reported an increased number of PMNs in NPs-induced pulmonary inﬂammation, there are
few studies investigating the effects and the mode of action of NPs on neutrophils. The following sections
will cover different studies that has been done regarding the effects of some NPs on PMN cell physiology.
AlthoughthewellaccepteddeﬁnitionofaNPis aparticle <100nm,wewillalsodiscusstheroleofparticles
greater than 100nm in size, since the literature regarding the interaction between NPs and neutrophils is
poorly documented.
3. NEUTROPHIL ACTIVATION BY NANOPARTICLES: A REVIEW
3.1. Review of the Literature (the 80s)
One of the ﬁrst studies investigating the interaction between NPs and neutrophils was done in 1988;
Hedenborg published that titanium dioxide (TiO2) dust induced the production of ROS by human neu-
trophils as measured by a chemiluminescence assay. Different dust particles (ranging in size from 345 to
1000nm) were tested, and none of them were cytotoxic, as assessed by lysozyme release or trypan blue
exclusion [18]. It was concluded that TiO2 stimulated the chemiluminescence activity of PMNs in a con-
centration-dependentmannerandthatparticlesizeandsurfacestructureofthedustwereimportantfordeter-
mining the intensity of the response.
3.2. Review of the Literature (the 90s)
In 1991, Papatheofanis and Barmada incubated human PMNs with increasing concentrations of polymeth-
ylmethacrylate(PMMA) NPs (50–60nm)in vitro andfoundthat this inducedthe releaseoflactate dehydro-
genase, lysosome, and beta-glucuronidase in a dose-dependent fashion [19]. Conversely, they reported that
PMMA NPs diminished migration of PMNs in a dose-dependent manner, as assessed by measuring the
distance attained by the leading front of cells in Boyden chambers. Polystyrene beads (50nm in diameter)
wereemployedasaphysicalcontrolin allexperimentsand,althoughtheyaffected the tested functionswhen
compared with cells incubated with buffer alone, the intensity of the response was always inferior to that of
PMMA NPs.
Using solid lipid NPs (SLN) produced by high pressure homogenisation of melted lipids (glycer-
olbehenate, cetylpalmitate), M¨ uller et al. reported in 1996 that modifying the surface of these NPs with hy-
drophilic poloxamine 908 and poloxamer 407 blockcopolymers generated slightly different results regard-
ing the phagocytic uptake and cell viability of human PMNs [20]. Of note, the viability was always greater
than 80% for all tested NPs ranging from a diameter of 123 to 246nm, as assessed by the colorimetric
MTT (dimethylthiazolyl-diphenyltetrazolium) assay. Modiﬁcation of the solid lipid NPs with poloxamine
908 and poloxamer 407 reduced phagocytic uptake by human PMNs to about 8–15% of the phagocytic up-
take of hydrophobic polystyrene particles. In another study conducted by M¨ uller and collaborators [20],
the in vitro cytotoxicity of SLN was investigated as a function of lipid matrix and stabilizing surfactant in
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human PMNs as well as in promyelocyte HL-60 cells. These latter cells, which can be differentiated toward
neutrophil-like cells, were used for comparison with fully mature PMNs isolated from the blood of healthy
volunteers, with the interest of using them to replace the daily isolation that is costly and time consuming.
They found that the nature of the lipid had no effect on the cell viability in either PMNs or HL-60 cells, but
that some distinct differences were found for the surfactants. For example, binding of poloxamer 184 to the
SLN surface reduced the cytotoxicity of the surfactant by a factor of ∼65. They concluded that HL-60 cells
represented a potentially good model for replacement of primary PMNs, but, as it will discussed later, this
is not always the case.
3.3. Review of the Literature (Since 2000)
Due to the increasing popularity of nanobiotechnologies land, the growing interest in nanotoxicology, a
seriesofstudieswereconductedmore recently.However,althoughseveralstudiesfocussingon lunginﬂam-
mation induced by NPs in animal models have reported that the presence of PMNs is increased, few studies
have examined the role and mode of action of a given NP directly on PMNs.
4. NONHUMAN NEUTROPHILS
4.1. Fish PMNs
Two studies have usedﬁsh neutrophils to investigatethe effect of hydroxylatedfullerenes (h-fullerenes) and
nanosized TiO2 [21, 22]. In these two studies (conducted by the same team), granulocytes were isolated
from the kidneys of fathead minnows; more than ∼80% of cells were positive for myeloperoxidase(MPO),
indicating that the vast majority of cells were of a myelopoietic lineage.
In the ﬁrst study, h-fullerenes (0.2–200μg/mL) were found to inhibit oxidative burst (carboxy-
H2DFFDA probe)as well asdegranulationof primary granules(MPO release)in a concentration-dependent
fashion [22]. In addition,theyreported that h-fullerenesinducedNETosisorthe releaseofNETs(neutrophil
extracellular traps) in a bell-shaped concentration-response curve as assessed by quantiﬁcation of DNA in
the supernatants after 2h of incubation. The maximum effect was observed at a concentration of 2μg/mL.
The size distribution of the particles varied from 164 to 1990nm in HBSS without Ca2+,M g 2+; 531 to
111nm in HBSS with Ca2+ and Mg2+; or 615 to 2300nm in egg water. Some agglomerates composed of
about2–10NPs wereconﬁrmedby microscopicimaging.Interestingly, a bimodal distribution was observed
when particle were dissolvedin HBSS without Ca2+ and Mg2+ (one peak at 235 and one at 1370nm) while
an unimodal distribution was observed in HBSS with Ca2+ and Mg2+ (peak at 814nm) and in egg water
(peak at 1250nm). Although the toxicity of the NPs was tested in vivo and revealed no signiﬁcant mortality
in the minnows, there is no information regarding the potential cytotoxicity of the NPs to PMNs in vitro at
the tested concentrations.
Similar experiments were conductedin the second study, except that ﬁsh PMNs were incubated with
TiO2 NPs(0.1–1000μg/mL)insteadofh-fullerenes.Theyreportedthat TiO2 NPsalsoincreasedrespiratory
burst when used alone or in combination with PMA [21]. However, NETs release was not observed when
cells were incubated with TiO2 NPs alone but was noticed when incubated in combination with the classical
neutrophil agonist phorbol 12-myristate 13-acetate (PMA). TiO2 NPs did not modulate degranulation when
used alone or in preactivatedcells. In another study, the size distribution of the TiO2 NPs was evaluated.An
unimodal distribution was observedin HBSS with or without Ca2+ and Mg2+ (peakat 66 and 88nm, resp.),
while a multimodal distribution was observed in egg water, with three major peaks at 1, 7, and 75nm.
4.2. Rat PMNs
PMNs were harvested following induction of peritonitis and were then incubated in vitro with poly(lactide
acid) NPs alone (PLA) or in combination with poly(ethylene glycol) PEG (PLA/PEG) at 250μg/mL.
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TheproductionofROSduetotheoxidativeburstofPMNsfollowingphagocytosisofPLAorPLA/PEGwas
measured by chemiluminescence [23]. The mean diameter of the NPs was 266 ± 15nm, 328 ± 9nm,and
374 ± 3nm for PLA, PLA/PEG (1:0.25), and PLA/PEG (1:1), respectively. Similar ROS production was
observedwhen PMNs were activated by PLA or PLA/PEG (1:0.25), but lower production was observedby
activation with PLA/PEG (1:1), probably due to the hydrophilic characteristics of PEG forming a solvated
layer coating the NPs surface, as mentioned by the authors. Such a phenomenon would lead to decreased
phagocytosis by preventing opsonization. Interestingly, analysis of phagocytosis by microscopy revealed
that,unlikethepositivecontrolzymosan,inwhich100%ofcellswereactivated,asevidencedbytheappear-
anceoflargeintracellularvacuolesinPMNs,only∼50%ofcellswereactivatedbyPLAorPLA/PEG(1:1).
4.3. Human PMNs
In 2002, Kumazawa and colleagues, using titanium (Ti), vanadium (V), and nickel (Ni) particles at 2 and
10ppm, investigated neutrophil responses [24]. In solution, only Ni was found to decrease cell survival rate
(trypanblueexclusion)andtoincreasethereleaseoflactatedehydrogenase(LDH).UnlikeNi,bothTiandV
particles stimulated PMNs to increase superoxide (O2
−) production, as assessedby the ferrocytochrome re-
duction assay. The amount of TNF-α released by PMNs was measured by ELISA and was only increased
by small Ti particles (diameter of 1–3μm) whereas this effect was not observed when the particle size was
larger (10μm). Using scanning electron microscopy, they showed that only Ni in solution destroyed the
cell membrane of PMNs. They also reported that only Ti particles (1–3μm) in solution were engulfed by
PMNs. This is one of the ﬁrst studies reporting that the cytotoxicity of a particle (Ti) is size dependent and
that PMN functions are modulated differently by the size of particles.
Memisoglu-Bilensoy et al. [25] determined the cytotoxicity of injectable cyclodextrin nanoparticles/
nanocapsules (speciﬁcally, β-CDC6) against mouse L929 ﬁbroblasts and human PMNs. The objective was
to evaluate their cytotoxicity with or without the presence of PF68, the most commonly used surfactant in
NPs formulations and which is designed to be potentially utilized as an injectable nanosized drug carrier.
Depending on the formulation, the particle size distribution was between ∼110 and 350nm. The cytotox-
icity was determined using the MTT assay, and the authors concluded that β-CDC6 NPs do not exert a sig-
niﬁcantcytotoxicityagainstﬁbroblastsnorPMNs.However,althoughthe experimentalconditions,in which
cells were incubated for 3 days before performing the assay, were appropriate for ﬁbroblasts, this was not
necessarily the same for PMNs, since these cells are known to spontaneously undergo apoptosis when
incubated in vitro (about 50% of PMNs are in apoptosis after only 24h) [26, 27].
The interaction between cholesteryl butyrate (chol-but) solid lipid NPs and PMNs was investigated
by Dianzani and colleagues[28]. In vitro incubation of PMNs with 10−8–10−4 M cholesteryl-butyrate solid
lipid nanoparticles (chol-but SLN, mean diameter of 130–160nm) for a period of time ranging from 10 to
240min did not lead to cytotoxic effects as measured by trypan blue exclusion [28]. Also, chol-but SLN
were found to inhibit adhesion of PMNs onto foetal calf serum-coated plastic wells as well as onto human
umbilical vein endothelial cells. Finally, in this study, the ability of FMLP-induced O2
− production and
FLMP-induced MPO release by PMNs was rapidly inhibited by chol-but SLN treatment.
More recently, the capacity of human immune cells to internalize rod-shaped and spherical gold NPs
(AuNPs), with diameters ranging between 15 and 50nm and a variety of surface chemistries, has been
determined. In contrast to monocytes-macrophagesthat ingest AuNPs [29], PMNs were found to trap them
in their extracellular structures, the NETs being composed mainly of DNA and a variety of antibacterial
proteins [30]. Interestingly, the cell-gold networks, visible after as early as 15min of treatment of immune
cells with the AuNPs, were predominantly observed in PMNs and, to a lesser extent, in monocytes and
macrophages. Such a mechanism indicates that NETs act as a physical barrier for NPs. In addition, in this
study, Bartneck et al. demonstrated that particle shape is not very important for particle trapping whereas
the positive charges signiﬁcantly enhance this phenomenon [30].
Our laboratory has been interested in investigating the role of NPs in various human PMN functions,
rather than focussing on only one (or very few) function, in order to get a more generalized picture on the
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mode of action of NPs on PMNs cell physiology [31]. TiO2 NPs were selected for our ﬁrst study since it is
presently the most studied NP reported in the literature. We used a commercially available preparation of
TiO2 NPs (anatasecrystals)of 1–10nm (90%)in size,asdetermined bytransmissionelectronic microscopy
(mentioned in the technical data sheet and also conﬁrmed by us). We ﬁrst incubated freshly isolated human
PMNs with increasing concentrations of TiO2 NPs (0–800μg/mL) over time and determined if the NPs
were cytotoxic. As assessed by trypan blue exclusion, the NPs did not decrease cell viability and only a
small portion of about 1–3% of cells were typically in necrosis after 24h of incubation at the highest con-
centration tested. Next, we determined whether or not TiO2 NPs could induce morphological changes.
After 24h, the optimal concentration inducing cell shape changes was 100μg/mL, a concentration used by
others with human lymphocytes [32]. Of note, others reported the use of TiO2 NPs at up to 4000μg/mL for
evaluating apoptosis in U937 human monoblastoid cell line [33]. Next, we found that TiO2 NPs induced
rapid phosphorylation events in PMNs as quickly as 15 seconds, with a maximal effect at 1 minute of
treatment, as assessed by monitoring phosphotyrosine residues. More speciﬁcally, we identiﬁed Erk-1/2
and p38 MAP kinases, two major enzymes involved in different PMNs functions, as targets of TiO2 NPs.
In accordancewith the aboveresults demonstrating that the NPs are not cytotoxic, we reported in this study
that they signiﬁcantly inhibited PMN apoptosis at 50 and 100μg/mL. Using an antibody array allowing
the simultaneous detection of 36 different cytokines/chemokines, TiO2 NPs were found to induce the
production of 13 analytes, including IL-8 and Gro-α, which exhibited the greatest increase (∼16 times and
∼4 times the levels of control cells, resp.). An ELISA assayallowed us to quantify that the NPs induced the
production of more than 1200pg/mL of IL-8 in the supernatants of TiO2-induced PMNs.
5. PERSPECTIVES
The studies discussedabovehave focussedmainly on in vitro activity of a givenNP on neutrophils. Most of
thesestudiesevaluatedthe cytotoxicityand/oronlyoneorfew PMNresponses.No studyotherthanourown
has determined the PMN apoptotic rate in response to NPs. However, more recent reports have investigated
the interaction between NPs and PMNs by studying several different functions/responses, an approach that
we encourage. For example, the fact that we found that TiO2 NPs can induce the production of several
analytes, including two potent chemokines (IL-8 and Gro-α), indicates that NPs can target PMNs that, in
turn, could activate other cells [31]. We suspect that, in the forthcoming years, this area of research will
become more signiﬁcant and more studies will be pursued. We also believe that, in addition to investigating
the mode of action of NPs in PMNs in vitro, it will be critical to determine the role of NPs in ex vivo
experiments in animal models. Furthermore, determining if a given NP is proinﬂammatory or not in vivo
in other models than those exclusively targeting the lungs will help us better evaluate the potential toxic
mechanisms of NPs. Using the murine air pouch model, we have recently demonstrated that administration
of a single dose of TiO2 NPs into the air pouch can attract leukocytes after 3–9h, where more than 80%
of cells are PMNs [34]. In addition, in this study, we reported that TiO2 NPs induced the production of
several chemokines locally present in the murine air pouch exudates. This model is a simple model that
allowed us to investigate an acute inﬂammatory response, the ﬁrst step leading to chronic inﬂammation
when deregulation occurs, such as the many studies reporting an increased number of PMNs in lung/BALS
[35–42]. On the other hand, the fact that a NP possesses some proinﬂammatory properties could be of help
for the design of drug delivery by NPs for clinical purposes. In this regards, one can imagine attracting
leukocytes such as PMNs into an inﬂammatory site by a NP delivering (or coated with) a neutrophil
proapoptotic molecule. Although this is speculative at the moment, this remains an interesting avenue of
research that needs to be explored in the future.
Information on how a NP with a different size or form will differently activate PMNs is of interest,
as is the ability (or not) of PMNs to ingest NPs. Recently, Kagan et al. demonstrated that carbon nanotubes
degradedby neutrophil MPO were found to be less proinﬂammatory in a model of pulmonary inﬂammation
[42]. This is one exampleindicating the importance of investigatingthe interaction between NPs and PMNs.
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Our laboratory will investigate the direct effect of several distinct NPs on human PMN cell physi-
ology in vitro. Using primary human cells for these studies is certainly more expensiveand time consuming
than using cell lines, since we have to isolate PMNs daily from blood donors, but the results are more easily
interpretable for the evaluation of human risk. Furthermore, the two major human cell lines that can be
driven by chemical treatment into “neutrophils-like cells,” the HL-60 and PLB-985 cell lines, are not real
PMNs and can respond differently than PMNs [43, 44]. Although we will investigate the immunomodula-
tory properties of a given NP on different PMNs functions in vitro, we will also determine cell signalling
pathways involved as well as identify the nature of some PMN proteins that will be targets to NPs. This
will be of great help for the elucidation of the mode of action of the tested NPs. In addition, we will pursue
investigating the proinﬂammatory effect of NPs using the murine air pouch model [34] as a simple reliable
model of acute inﬂammation. For example, in addition to the identiﬁcation of cytokines/chemokines and
leukocyte populations in kinetic and concentration-dependent experiments, this will lead to a classiﬁcation
of different NPs according to their degree of proinﬂammatory properties.
ABBREVIATIONS
NP: Nanoparticle
PMNs: Polymorphonuclear neutrophil cells
ROS: Reactive oxygen species
TiO2: Titanium dioxide
PMMA: Polymethylmethacrylate
SLN: Solid lipid NPs
MTT: Dimethylthiazolyl-diphenyltetrazolium
h-fullerenes: Hydroxylated fullerenes
MPO: Myeloperoxidase
NETs: Neutrophil extracellular traps
PLA: Poly-lactide acid
PEG: Polyethylene glycol
LDH: Lactate dehydrogenase
O2
−: Superoxide
Chol-but: Cholesteryl-butyrate.
ACKNOWLEDGMENTS
This study was supported by the Institut de recherche Robert-Sauv´ ee ns a n t ´ ee te ns ´ ecurit´ ed ut r a v a i l
(IRSST). D. M. Goncalves holds a Ph.D. degree in natural sciences and Engineering Research Council
of Canada (NSERC) Award and R. de Liz holds a doctoral award from the Brazilian governmentfor a train-
ing abroad. The authors thank Mary Gregory for reading this paper.
REFERENCES
[1] C. Buzea, I. I. Pacheco, and K. Robbie, “Nanomaterials and nanoparticles: sources and toxicity,” Biointerphases,
vol. 2, pp. 17–71, 2007.
[2] The Royal Society, “Nanoscience and nanotechnologies: opportunities and uncertainties,” 2004, page 127.
[3] C. Ostiguy, “IRSST-Les effets ` al as a n t´ er e l i´ es aux nanoparticules(Montr´ eal: institut de Recherche Robert-Sauv´ e
en sant´ ee ts´ ecurit´ e au travail ),” 2006, page 155.
[4] T. J. Webster, “Safety of Nanoparticles: From Manufacturing to medical applications,” 2009, Providence, RI,
USA.
[5] J. S. Tsuji, A. D. Maynard, P. C. Howard et al., “Research strategies for safety evaluation of nanomaterials, part
IV: risk assessment of nanoparticles,” Toxicological Sciences, vol. 89, no. 1, pp. 42–50, 2006.
1883TheScientiﬁcWorldJOURNAL (2011) 11, 1877–1885
[6] A. D. Maynard, “Nanotechnology: the next big thing, or much ado about nothing?” Annals of Occupational
Hygiene, vol. 51, no. 1, pp. 1–12, 2007.
[7] G. Oberd¨ orster, E. Oberd¨ orster, and J. Oberd¨ orster, “Nanotoxicology: an emerging discipline evolving from
studies of ultraﬁne particles,” Environmental Health Perspectives, vol. 113, no. 7, pp. 823–839, 2005.
[8] EPA-Nanotechnology-White-Paper,“Nanotechnology White Paper. U.S.E.P.A. (EPA),” 2007, page 120.
[9] S. W. Edwards and M. B. Hallett, “Seeing the wood for the trees: the forgotten role of neutrophils in rheumatoid
arthritis,” Immunology Today, vol. 18, no. 7, pp. 320–324, 1997.
[10] A. P. Watt, B. C. Schock, and M. Ennis, “Neutrophils and eosinophils: clinical implications of their appearance,
presence and disappearance in asthma and COPD,” Current Drug Targets, vol. 4, no. 4, pp. 415–423, 2005.
[11] L. Ottonello, G. Frumento, N. Arduino et al., “Delayed neutrophil apoptosis induced by synovial ﬂuid in rheu-
matoid arthritis: role of cytokines, estrogens, and adenosine,” Annals of the New York Academy of Sciences,v o l .
966, pp. 226–231, 2002.
[12] O. J. Cordero, F. J. Salgado, A. Mera-Varela, and M. Nogueira, “Serum interleukin-12, interleukin-15, soluble
CD26, and adenosine deaminase in patients with rheumatoid arthritis,” Rheumatology International, vol. 21, no.
2, pp. 69–74, 2001.
[13] G. Steiner, M. Tohidast-Akrad, G. Witzmann et al., “Cytokine production by synovial T cells in rheumatoid
arthritis,” Rheumatology, vol. 38, no. 3, pp. 202–213, 1999.
[14] C. Ward, I. Dransﬁeld,E. R. Chilvers, C. Haslett, andA. G. Rossi, “Pharmacologicalmanipulationofgranulocyte
apoptosis:potentialtherapeutictargets,”Trends in PharmacologicalSciences,vol. 20,no. 12, pp. 503–509,1999.
[15] S. W. EdwardsandF. Watson, “Thecell biologyofphagocytes,”ImmunologyToday,vol. 16,no.11,pp. 508–510,
1995.
[16] M. Pelletier, A. Bouchard, and D. Girard, “In vivo and in vitro roles of IL-21 in inﬂammation,” Journal of
Immunology, vol. 173, no. 12, pp. 7521–7530,2004.
[17] M. Pelletier and D. Girard, “Biological functions of interleukin-21 and its role in inﬂammation,” TheScientiﬁc-
WorldJournal, vol. 7, pp. 1715–1735,2007.
[18] M. Hedenborg, “Titanium dioxide induced chemiluminescence of human polymorphonuclear leukocytes,”
InternationalArchives of Occupationaland Environmental Health, vol. 61, no. 1-2, pp. 1–6, 1988.
[19] F. J. Papatheofanis and R. Barmada, “Polymorphonuclearleukocyte degranulation with exposure to polymethyl-
methacrylate nanoparticles,” Journal of Biomedical Materials Research, vol. 25, no. 6, pp. 761–771, 1991.
[20] R. H. M¨ uller, S. Maaßen, H. Weyhers, and W. Mehnert, “Phagocytic uptake and cytotoxicity of solid lipid
nanoparticles (SLN) sterically stabilized with poloxamine 908 and poloxamer 407,” Journal of Drug Targeting,
vol. 4, no. 3, pp. 161–170, 1996.
[21] B. Jovanovi´ c, L. Anastasova, E. W. Rowe, Y. Zhang, A. R. Clapp, and D. Pali´ c, “Effects of nanosized titanium
dioxide on innate immune system of fathead minnow (Pimephales promelas Raﬁnesque, 1820),” Ecotoxicology
and Environmental Safety, vol. 74, no. 4, pp. 675–683, 2011.
[22] B. Jovanovi´ c, L. Anastasova, E. W. Rowe, and D. Pali´ c, “Hydroxylated fullerenes inhibit neutrophil function in
fathead minnow (Pimephales promelas Raﬁnesque, 1820),” Aquatic Toxicology, vol. 101, no. 2, pp. 474–482,
2011.
[23] R. M. Mainardes, M. P. D. Gremi˜ ao,I. L. Brunetti, M. D. Luiz Fonseca, and N. M. Khalil, “Pharmaceuticalnano-
technologyzidovudine-loadedPLA and PLA-PEG blend nanoparticles: inﬂuence of polymer type on phagocytic
uptake by polymorphonuclearcells,” Journal of Pharmaceutical Sciences, vol. 98, no. 1, pp. 257–267, 2009.
[24] R. Kumazawa, F. Watari, N. Takashi, Y. Tanimura, M. Uo, and Y. Totsuka, “Effects of Ti ions and particles on
neutrophil function and morphology,”Biomaterials, vol. 23, no. 17, pp. 3757–3764,2002.
[25] E. Memisoglu-Bilensoy, A. L. Do˘ gan, and A. A. Hincal, “Cytotoxic evaluation of injectable cyclodextrin nano-
particles,” Journal of Pharmacy and Pharmacology, vol. 58, no. 5, pp. 585–589, 2006.
[26] R. Dufﬁn, A. E. Leitch, S. Fox, C. Haslett, and A. G. Rossi, “Targeting granulocyte apoptosis: mechanisms,
models, and therapies,” ImmunologicalReviews, vol. 236, no. 1, pp. 28–40, 2010.
[27] V. Lavastre, M. Pelletier, R. Saller, K. Hostanska, and D. Girard, “Mechanisms involved in spontaneous and
Viscum album agglutinin-I-induced human neutrophil apoptosis: viscum album agglutinin-I accelerates the loss
of antiapoptotic Mcl-1 expression and the degradation of cytoskeletal paxillin and vimentin proteins via caspas-
es,” Journal of Immunology, vol. 168, no. 3, pp. 1419–1427,2002.
[28] C. Dianzani,R. Cavalli, G. P. Zaraet al.,“Cholesterylbutyratesolid lipidnanoparticlesinhibitadhesionofhuman
neutrophils to endothelial cells,” British Journal of Pharmacology, vol. 148, no. 5, pp. 648–656, 2006.
1884TheScientiﬁcWorldJOURNAL (2011) 11, 1877–1885
[29] M. Bartneck, H. A. Keul, S. Singh et al., “Rapid uptake of gold nanorods by primary human blood phagocytes
and immunomodulatoryeffects of surface chemistry,” ACS Nano, vol. 4, no. 6, pp. 3073–3086,2010.
[30] M. Bartneck, H. A. Keul, Z. K. Gabriele, and J. Groll, “Phagocytosis independent extracellular nanoparticle
clearance by human immune cells,” Nano Letters, vol. 10, no. 1, pp. 59–64, 2010.
[31] D. M. Gonc ¸alves, S. Chiasson, and D. Girard, “Activation of human neutrophils by titanium dioxide (TiO2)
nanoparticles,” Toxicology in Vitro, vol. 24, no. 3, pp. 1002–1008,2010.
[32] S. J. Kang, B. M. Kim, Y. J. Lee, S. H. Hong, and H. W. Chung, “Titanium dioxide nanoparticles induce apop-
tosis through the JNK/p38-caspase-8-Bid pathway in phytohemagglutinin-stimulatedhuman lymphocytes,” Bio-
chemical and Biophysical Research Communications, vol. 386, no. 4, pp. 682–687, 2009.
[33] C. I. Vamanu, M. R. Cimpan, P. J. Høl, S. Sørnes, S. A. Lie, and N. R. Gjerdet, “Induction of cell death by TiO2
nanoparticles: studies on a human monoblastoid cell line,” Toxicology in Vitro, vol. 22, no. 7, pp. 1689–1696,
2008.
[34] D. M. Goncalves and D. Girard, “Titanium dioxide (TiO(2)) nanoparticles induce neutrophil inﬂux and local
production of several pro-inﬂammatory mediators in vivo,” International Immunopharmacology, vol. 11, no. 8,
pp. 1109–1115,2011.
[35] A. Srinivas, P. J. Rao, G. Selvam, P. B. Murthy, and P. N. Reddy, “Acute inhalation toxicity of cerium oxide
nanoparticles in rats,” Toxicology Letters, vol. 205, no. 2, pp. 105–115, 2011.
[36] C. M. Sayes, K. L. Reed, and D. B. Warheit, “Nanoparticle toxicology: measurements of pulmonary hazard
effects following exposures to nanoparticles,” Methods in Molecular Biology, vol. 726, pp. 313–324, 2011.
[37] S. Hussain, J. A.J. Vanoirbeek,K. Luyts et al., “Lung exposureto nanoparticlesmodulates an asthmatic response
in a mouse model,” European Respiratory Journal, vol. 37, no. 2, pp. 299–309, 2011.
[38] M. Roursgaard, S. S. Poulsen, L. K. Poulsen et al., “Time-response relationship of nano and micro particle
induced lung inﬂammation. Quartz as reference compound,” Human and Experimental Toxicology, vol. 29, no.
11, pp. 915–933, 2010.
[39] E. M. Rossi, L. Pylkk¨ anen, A. J. Koivisto et al., “Airway exposure to silica-coated TiO2 nanoparticles induces
pulmonary neutrophilia in mice,” Toxicological Sciences, vol. 113, no. 2, pp. 422–433, 2009.
[40] S. T. Larsen, M. Roursgaard, K. A. Jensen, and G. D. Nielsen, “Nano titanium dioxide particles promote allergic
sensitization and lung inﬂammation in mice,” Basic and Clinical Pharmacology and Toxicology, vol. 106, no. 2,
pp. 114–117, 2010.
[41] N. R. Jacobsen, P. Møller, K. A. Jensen et al., “Lung inﬂammation and genotoxicity following pulmonary
exposure to nanoparticles in ApoE-/-mice,” Particle and Fibre Toxicology, vol. 6, article 2, 2009.
[42] V. E. Kagan, N. V. Konduru, W. Feng et al., “Carbon nanotubes degraded by neutrophil myeloperoxidase induce
less pulmonary inﬂammation,” Nature Nanotechnology, vol. 5, no. 5, pp. 354–359, 2010.
[43] M. Pelletier, A. Savoie, and D. Girard, “Activation of human neutrophils by the air pollutant sodium sulﬁte
(NA2SO3): comparison with immature promyelocytic HL-60 and DMSO-differentiated HL-60 cells reveals that
NA2SO3 is a neutrophil but not a HL-60 cell agonist,” Clinical Immunology, vol. 96, no. 2, pp. 131–139, 2000.
[44] C. Ratth´ e andD. Girard,“Investigationof the interleukin(IL)-4/IL-4receptorsystem in promyelocyticleukaemia
PLB-985 cells during differentiation toward neutrophil-like phenotype: mechanism involved in IL-4-induced
SOCS3 protein expression,” British Journal of Haematology, vol. 140, no. 1, pp. 59–70, 2008.
This article should be cited as follows:
David M. Goncalves, Rafael de Liz, and Denis Girard, “Activation of Neutrophils by Nanoparticles,”
TheScientiﬁcWorldJOURNAL,vol. 11, pp. 1877–1885, 2011.
1885